These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
311 related items for PubMed ID: 17412302
1. Influenza vaccination in systemic lupus erythematosus: safe and protective? Holvast B, Huckriede A, Kallenberg CG, Bijl M. Autoimmun Rev; 2007 Apr; 6(5):300-5. PubMed ID: 17412302 [Abstract] [Full Text] [Related]
2. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus. Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M. Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961 [Abstract] [Full Text] [Related]
3. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Holvast A, Huckriede A, Wilschut J, Horst G, De Vries JJ, Benne CA, Kallenberg CG, Bijl M. Ann Rheum Dis; 2006 Jul; 65(7):913-8. PubMed ID: 16322083 [Abstract] [Full Text] [Related]
4. Influenza vaccination of patients with systemic lupus erythematosus: safety and immunogenecity issues. Abu-Shakra M, Press J, Buskila D, Sukenik S. Autoimmun Rev; 2007 Sep; 6(8):543-6. PubMed ID: 17854746 [Abstract] [Full Text] [Related]
5. Safety and efficiency of influenza vaccination in systemic lupus erythematosus patients. Wallin L, Quintilio W, Locatelli F, Cassel A, Silva MB, Skare TL. Acta Reumatol Port; 2009 Sep; 34(3):498-502. PubMed ID: 19820674 [Abstract] [Full Text] [Related]
6. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study. Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M. Rheumatology (Oxford); 2009 Oct; 48(10):1294-9. PubMed ID: 19692457 [Abstract] [Full Text] [Related]
7. Specific antibody response after influenza immunization in systemic lupus erythematosus. Abu-Shakra M, Press J, Varsano N, Levy V, Mendelson E, Sukenik S, Buskila D. J Rheumatol; 2002 Dec; 29(12):2555-7. PubMed ID: 12465151 [Abstract] [Full Text] [Related]
9. Influenza vaccination of patients with systemic lupus erythematosus. Mercado U, Acosta H, Avendaño L. Rev Invest Clin; 2004 Dec; 56(1):16-20. PubMed ID: 15144037 [Abstract] [Full Text] [Related]
10. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Del Porto F, Laganà B, Biselli R, Donatelli I, Campitelli L, Nisini R, Cardelli P, Rossi F, D'Amelio R. Vaccine; 2006 Apr 12; 24(16):3217-23. PubMed ID: 16466833 [Abstract] [Full Text] [Related]
11. Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Stojanovich L. Clin Dev Immunol; 2006 Apr 12; 13(2-4):373-5. PubMed ID: 17162380 [Abstract] [Full Text] [Related]
12. [Should we vaccinate patients with systemic lupus]. Wiesik-Szewczyk E, Lacki JK, Chwalińiska-Sadowska H. Pol Merkur Lekarski; 2007 Nov 12; 23(137):395-8. PubMed ID: 18361328 [Abstract] [Full Text] [Related]
13. Control of humoral immunity and auto-immunity by the CXCR4/CXCL12 axis in lupus patients following influenza vaccine. Launay O, Paul S, Servettaz A, Roguet G, Rozenberg F, Lucht F, Lambert C, Presles E, Goulvestre C, Méritet JF, Galtier F, Dubray C, Lebon P, Weill B, Batteux F. Vaccine; 2013 Aug 02; 31(35):3492-501. PubMed ID: 23764537 [Abstract] [Full Text] [Related]
14. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice. Tao P, Luo M, Pan R, Ling D, Zhou S, Tien P, Pan Z. Antiviral Res; 2009 Mar 02; 81(3):253-60. PubMed ID: 19135483 [Abstract] [Full Text] [Related]
15. Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity. Murdaca G, Orsi A, Spanò F, Puppo F, Durando P, Icardi G, Ansaldi F. Autoimmun Rev; 2014 Feb 02; 13(2):75-84. PubMed ID: 24044940 [Abstract] [Full Text] [Related]
16. Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity. Abu-Shakra M, Zalmanson S, Neumann L, Flusser D, Sukenik S, Buskila D. J Rheumatol; 2000 Jul 02; 27(7):1681-5. PubMed ID: 10914851 [Abstract] [Full Text] [Related]
17. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host. Paillot R, Grimmett H, Elton D, Daly JM. Vet Res; 2008 Jul 02; 39(3):21. PubMed ID: 18252187 [Abstract] [Full Text] [Related]
18. Vaccination in patients with chronic rheumatic or autoimmune diseases. Glück T, Müller-Ladner U. Clin Infect Dis; 2008 May 01; 46(9):1459-65. PubMed ID: 18419456 [Abstract] [Full Text] [Related]
19. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. Scharpé J, Peetermans WE, Vanwalleghem J, Maes B, Bammens B, Claes K, Osterhaus AD, Vanrenterghem Y, Evenepoel P. Am J Kidney Dis; 2009 Jul 01; 54(1):77-85. PubMed ID: 19339089 [Abstract] [Full Text] [Related]
20. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain. Droebner K, Haasbach E, Fuchs C, Weinzierl AO, Stevanovic S, Büttner M, Planz O. Vaccine; 2008 Dec 09; 26(52):6965-74. PubMed ID: 18848593 [Abstract] [Full Text] [Related] Page: [Next] [New Search]